Arch Biopartners Inc.
ARCH.V
TSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 59.68% | -15.67% | -147.02% | -827.40% | -1,439.28% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -91.31% | 31.47% | 1,208.19% | 191.47% | 214.97% |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | 39.02% | -1.48% | 123.89% | 89.03% | -124.83% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -29.89% | -100.00% |
| Total Debt Repaid | -1,675.00% | -41.79% | -79.45% | -79.45% | 95.06% |
| Issuance of Common Stock | -83.89% | -83.89% | -88.01% | -79.05% | 144.67% |
| Repurchase of Common Stock | 52.57% | 52.57% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 386.05% | -100.00% |
| Cash from Financing | 423.42% | 545.02% | -49.10% | -85.07% | -74.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.71% | 116.89% | 156.79% | 97.33% | -2,017.56% |
